Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $259.07 in the prior trading day, Labcorp Holdings Inc (NYSE: LH) closed at $253.63, down -2.10%. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 1.38 million shares were traded. LH stock price reached its highest trading level at $259.47 during the session, while it also had its lowest trading level at $252.055.
Ratios:
Our goal is to gain a better understanding of LH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 57.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.60 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $276.
Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $250 to $300.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when ANDERSON KERRII B sold 500 shares for $265.00 per share. The transaction valued at 132,500 led to the insider holds 12,166 shares of the business.
ANDERSON KERRII B sold 500 shares of LH for $130,000 on Jun 11 ’25. The Director now owns 12,666 shares after completing the transaction at $260.00 per share. On Jun 11 ’25, another insider, KERRII ANDERSON, who serves as the Director of the company, bought 1,000 shares for $259.37 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 21228830720 and an Enterprise Value of 28201586688. As of this moment, Labcorp’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.26, and their Forward P/E ratio for the next fiscal year is 14.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.99. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.61 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is 16.422.
Stock Price History:
The Beta on a monthly basis for LH is 0.78, which has changed by 0.23019838 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, LH has reached a high of $265.72, while it has fallen to a 52-week low of $198.96. The 50-Day Moving Average of the stock is 0.35%, while the 200-Day Moving Average is calculated to be 6.33%.
Shares Statistics:
The stock has traded on average 768.76K shares per day over the past 3-months and 751350 shares per day over the last 10 days, according to various share statistics. A total of 83.80M shares are outstanding, with a floating share count of 83.39M. Insiders hold about 0.34% of the company’s shares, while institutions hold 95.52% stake in the company. Shares short for LH as of 1749772800 were 3440413 with a Short Ratio of 4.48, compared to 1747267200 on 2802154. Therefore, it implies a Short% of Shares Outstanding of 3440413 and a Short% of Float of 5.3400002.
Dividends & Splits
In the trailing 12 months, LH’s forward annual dividend rate was 2.88, compared to 2.88 this year. Against a Trailing Annual Dividend Yield of 0.011116686The current Payout Ratio is 32.58% for LH, which recently paid a dividend on 2025-05-29 with an ex-dividend date of 1748476800. Stock splits for the company last occurred on 2023-07-03 when the company split stock in a 1164:1000 ratio.
